Hamilton Thorne Ltd
XTSX:HTL
Intrinsic Value
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. [ Read More ]
The intrinsic value of one
HTL
stock under the Base Case scenario is
1.2
CAD.
Compared to the current market price of 1.45 CAD,
Hamilton Thorne Ltd
is
Overvalued by 17%.
Hamilton Thorne Ltd's market capitalization is 212.4m CAD.
HTL stock price is 1.45 CAD.
HTL stock (1.2 CAD) is 17% less than its price (1.45 CAD).
HTL stock (1.27 CAD) is 12% less than its price (1.45 CAD). Open Relative Valuation
HTL has upside potential of 63% compared to the average analyst price target.
Open Wall St Estimates
HTL's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 9%.
HTL's ROE (Return on Equity) has decreased in the last 3 years from 4% to 1%.
HTL's Revenue has grown by 11% over the past 12 months.
HTL's ROIC (Return on Invested Capital) has increased in the last 3 years from 6% to 9%.
HTL has positive Operating Income for the last twelve months.
HTL's ROE (Return on Equity) for the past 12 months is very low and is equal to 1%.
HTL has positive Free Cash Flow for the last twelve months.
HTL has positive Net Income for the last twelve months.
HTL has negative Net Debt. This means that the company has more cash and short-term investments (16m USD) than debt (16m USD).
HTL has positive three-year average ROIC (Return on Invested Capital): 5%. The company is efficient at using invested capital to generate operating income.
HTL's Revenue has been growing by 19% per year for the last 3 years.
HTL has a very low three-year average ROE (Return on Equity): 3%. The company is not efficient at transforming stockholders' equity into net income.
HTL has positive Gross Profit for the last twelve months.
HTL's short-term assets (39m USD) exceed its short-term liabilties (15m USD).
HTL's long-term assets (91m USD) exceed its long-term liabilties (33m USD).
HTL's D/E (Debt to Equity) is very low and is equal to 0.27.
HTL's Altman Z-Score is very high and is equal to 4.43.
HTL generates enough operating income (849k USD) to cover interest payments on its debt (551k USD).
Valuation Backtest
Hamilton Thorne Ltd
Run backtest to discover the historical profit from buying and selling
HTL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Hamilton Thorne Ltd
Balance Sheet Decomposition
Hamilton Thorne Ltd
| Current Assets | 39m |
| Cash & Short-Term Investments | 16.4m |
| Receivables | 7.8m |
| Other Current Assets | 14.9m |
| Non-Current Assets | 52.2m |
| PP&E | 8.6m |
| Intangibles | 39m |
| Other Non-Current Assets | 4.6m |
| Current Liabilities | 14.8m |
| Accounts Payable | 9.6m |
| Other Current Liabilities | 5.2m |
| Non-Current Liabilities | 18.1m |
| Long-Term Debt | 15.5m |
| Other Non-Current Liabilities | 2.6m |
Earnings Waterfall
Hamilton Thorne Ltd
|
Revenue
|
63m
USD
|
|
Cost of Revenue
|
-30.9m
USD
|
|
Gross Profit
|
32.1m
USD
|
|
Operating Expenses
|
-31.3m
USD
|
|
Operating Income
|
849.3k
USD
|
|
Other Expenses
|
-131.6k
USD
|
|
Net Income
|
717.8k
USD
|
Free Cash Flow Analysis
Hamilton Thorne Ltd
What is Free Cash Flow?
HTL Profitability Score
Profitability Due Diligence
Hamilton Thorne Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Hamilton Thorne Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
HTL Solvency Score
Solvency Due Diligence
Hamilton Thorne Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Score
Hamilton Thorne Ltd's solvency score is 60/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HTL Price Targets Summary
Hamilton Thorne Ltd
According to Wall Street analysts, the average 1-year price target for
HTL
is 2.37 CAD
.
Shareholder Return
HTL Price
Hamilton Thorne Ltd
| Average Annual Return | 22.76% |
| Standard Deviation of Annual Returns | 30.84% |
| Max Drawdown | -40% |
| Market Capitalization | 212.4m CAD |
| Shares Outstanding | 145 830 271 |
| Percentage of Shares Shorted | 0.01% |
Company Profile
Hamilton Thorne Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Hamilton Thorne Ltd. engages in the provision of laboratory instruments, consumables, software and services to the assisted reproductive technology (ART) and developmental biology research markets. The company is headquartered in Beverly, Massachusetts. The company went IPO on 2007-07-10. The firm's products lines include precision laser devices, imaging systems, micromanipulation systems, air purification systems, incubators, control rate freezers, and lab monitoring systems. Its GM501 product provides the In Vitro Fertilization (IVF)lab with a cell culture media solution, including oocyte handling, sperm processing, embryo culture, and cryopreservation. Its services offers a range of user needs, ranging from equipment service contract and maintenance programs, quality control testing services to manufacturers of medical devices, culture media and consumables used in IVF labs, and laboratory design and installation services. The firm's brands include Hamilton Thorne, Gynemed, Planer, IVFtech, Embryotech Laboratories, and Tek-Event.
Contact
IPO
Employees
Officers
The intrinsic value of one
HTL
stock under the Base Case scenario is
1.2
CAD.
Compared to the current market price of 1.45 CAD,
Hamilton Thorne Ltd
is
Overvalued by 17%.
You don't have any saved screeners yet
